University of Colorado, Boulder

OrganisationROR

People

Fisetin for Improving Vascular Function in Older Adults: A Phase II Clinical Trial
Phase 2, Not yet recruiting, 136 people, 13 Oct 2026
NCT07527338
Phase 2, Not yet recruiting, 58 people, 14 Apr 2026
Fisetin to Improve Vascular Function in Older Adults
Phase 1/2, Active, not recruiting, 70 people, 15 Nov 2023
Mitochondrial-targeted Antioxidant Supplementation for Improving Age-related Vascular Dysfunction in Humans
Phase 2, Completed, 112 people, 20 Apr 2021
NCT03223883
Collaborator, Phase 2, Completed, 94 people, 21 Jul 2017
NCT03060031
Phase 1, Completed, 51 people, 23 Feb 2017
NCT02921659
Phase 1/2, Completed, 30 people, 3 Oct 2016
NCT01595516
Phase 4, Completed, 44 people, 10 May 2012

American Heart Association
Transformational Project Award, Adipocyte-Derived Extracellular Vesicles; Novel Biomarker and Mediator of Obesity-Related Endothelial Dysfunction, 24TPA1301309, US$300k, 2024–2027, 1 Jul 2024
American Heart Association
Predoctoral Fellowship, Chronic MitoQ Supplementation for Improving Cerebrovascular Function in Older Adults, 24PRE1186290, US$67.4k, 2024, 1 Jan 2024
American Heart Association
Career Development Award, Clinical translation of senolytic therapy with fisetin to improve vascular function in older adults, 23CDA1056582, US$230k, 2023–2026, 1 Apr 2023
American Heart Association
Postdoctoral Fellowship, Mitochondria-targeted antioxidant supplementation for improving age-related vascular dysfunction in older adults, 23POST1025630, US$140.6k, 2023, 1 Jan 2023
American Heart Association
Postdoctoral Fellowship, Efficacy of inspiratory muscle strength training for improving blood pressure and vascular function in mid-life adults, 18POST33990034, US$104.1k, 2018–2020, 1 Jul 2018